BioArctic AB

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0010323311
SEK
317.20
-2 (-0.63%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
184.04
133.34
392.12
1,289.61
101.24
76.63
49.84
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
184.04
133.34
392.12
1,289.61
101.24
76.63
49.84
Raw Material Cost
15.06
12.22
20.49
11.44
11.85
8.09
4.81
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.93
2.67
16.07
14.23
0.66
0.62
0.46
Selling and Distribution Expenses
49.45
50.34
49.05
46.00
46.49
26.60
36.94
Other Expenses
7.99
9.29
9.58
7.04
9.56
6.78
8.31
Total Expenditure (Excl Depreciation)
149.36
158.07
181.46
142.08
154.61
103.06
125.28
Operating Profit (PBDIT) excl Other Income
34.7
-24.700000000000003
210.7
1147.5
-53.4
-26.400000000000002
-75.4
Other Income
9.33
6.46
-23.11
-67.32
10.13
7.35
7.46
Operating Profit (PBDIT)
47.16
-14.90
187.55
1,080.21
-43.25
-19.08
-67.97
Interest
4.93
2.67
16.07
14.23
0.66
0.62
0.46
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
168.97
121.12
371.63
1,278.17
89.39
68.55
45.03
Depreciation
3.15
3.37
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
39.07
-20.94
171.48
1,065.98
-43.91
-19.70
-68.43
Tax
47.90
65.93
74.93
44.51
-12.44
-0.07
-0.01
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-8.83
-86.87
96.55
1,021.47
-31.46
-19.63
-68.42
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-8.83
-86.87
96.55
1,021.47
-31.46
-19.63
-68.42
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-8.83
-86.87
96.55
1,021.47
-31.46
-19.63
-68.42
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Reserves
1,967.08
1,969.28
2,036.08
1,933.96
894.94
918.63
929.37
Earnings per share (EPS)
-0.1
-0.98
1.09
11.55
-0.36
-0.22
-0.77
Diluted Earnings per share
-0.1
-0.98
1.09
11.55
-0.36
-0.22
-0.77
Operating Profit Margin (Excl OI)
18.84%
-18.55%
53.72%
88.98%
-52.72%
-34.49%
-151.34%
Gross Profit Margin
22.94%
-13.18%
43.73%
82.66%
-43.37%
-25.7%
-137.29%
PAT Margin
-4.8%
-65.15%
24.62%
79.21%
-31.08%
-25.62%
-137.28%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 38.03% vs -66.00% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 89.87% vs -189.96% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 276.64% vs -110.16% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 81.48% vs -83.23% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of BioArctic AB With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
184.04
7,821.00
-7,636.96
-97.65%
Other Operating Income
0.00
0.00
0.00
Total Operating income
184.04
7,821.00
-7,636.96
-97.65%
Raw Material Cost
15.06
2,231.00
-2,215.94
-99.32%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.93
185.00
-180.07
-97.34%
Selling and Distribution Expenses
49.45
2,214.00
-2,164.55
-97.77%
Other Expenses
7.99
69.40
-61.41
-88.49%
Total Expenditure (Excl Depreciation)
149.36
5,324.00
-5,174.64
-97.19%
Operating Profit (PBDIT) excl Other Income
34.68
2,497.00
-2,462.32
-98.61%
Other Income
9.33
2.00
7.33
366.50%
Operating Profit (PBDIT)
47.16
3,253.00
-3,205.84
-98.55%
Interest
4.93
185.00
-180.07
-97.34%
Exceptional Items
0.00
-142.00
142.00
100.00%
Gross Profit (PBDT)
168.97
5,590.00
-5,421.03
-96.98%
Depreciation
3.15
754.00
-750.85
-99.58%
Profit Before Tax
39.07
2,174.00
-2,134.93
-98.20%
Tax
47.90
309.00
-261.10
-84.50%
Provisions and contingencies
0
0
0.00
Profit After Tax
-8.83
1,862.00
-1,870.83
-100.47%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-8.83
1,862.00
-1,870.83
-100.47%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-8.83
1,862.00
-1,870.83
-100.47%
Equity Capital
0
0
0.00
Face Value
0.02
0.00
0.00
Reserves
1,967.08
37,717.00
-35,749.92
-94.78%
Earnings per share (EPS)
-0.10
5.34
-5.44
-101.87%
Diluted Earnings per share
-0.10
5.34
-5.44
-101.87%
Operating Profit Margin (Excl OI)
18.84%
31.93%
0.00
-13.09%
Gross Profit Margin
22.94%
37.44%
0.00
-14.50%
PAT Margin
-4.80%
23.81%
0.00
-28.61%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 18.40 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 38.03% vs -66.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 81.82% vs 820.00% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit -0.88 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 89.87% vs -189.96% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 72.06% vs 63.88% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.78 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 276.64% vs -110.16% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 170.79% vs 28.61% in Dec 2024

Quarterly - Interest
Interest 0.49 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 81.48% vs -83.23% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 600.00% vs -91.76% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.84%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024